Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Research in health sciences, co-responsibility and social impact].

Adam P, Permanyer-Miralda G.

Med Clin (Barc). 2013 Sep 21;141(6):254-6. doi: 10.1016/j.medcli.2013.03.010. Epub 2013 May 10. Spanish. No abstract available.

PMID:
23664033
2.

Assessing payback from research investment.

Buys YM.

Can J Ophthalmol. 2010 Apr;45(2):113-4. doi: 10.3129/i10-003. English, French. No abstract available.

PMID:
20379291
3.

The role and responsibility of industry in research.

Lasagna L.

Dolentium Hominum. 1987;4(2nd Yr. 1):56-9. No abstract available.

PMID:
11653199
4.

Value for money is crucial in this age of austerity.

[No authors listed]

Lancet Oncol. 2009 Nov;10(11):1021. doi: 10.1016/S1470-2045(09)70319-5. No abstract available.

PMID:
19880054
5.

Philanthropy, medical research, and the role of development.

Wheeler JL, Rum SA, Wright SM.

Am J Med. 2014 Oct;127(10):903-4. doi: 10.1016/j.amjmed.2014.05.025. Epub 2014 May 22. No abstract available.

PMID:
24858063
6.

The realistic costs and benefits of translational research.

Schwab AP, Satin DJ.

Am J Bioeth. 2008 Mar;8(3):60-2; discussion W1-3. doi: 10.1080/15265160802109348. No abstract available.

PMID:
18570108
7.

New rules propose greater scrutiny for NIH grant recipients.

Dove A.

Nat Med. 2006 Jan;12(1):5. No abstract available.

PMID:
16397535
8.

The potential contributions of translational research and ethics.

Chapman AR.

Am J Bioeth. 2008 Mar;8(3):64-6; discussion W1-3. doi: 10.1080/15265160802109470. No abstract available.

PMID:
18570110
9.

Setting priorities for science support.

Dresser R.

Hastings Cent Rep. 1998 May-Jun;28(3):21-3. No abstract available.

PMID:
9669178
10.

NerveCenter: Biomedical research funding a vital part of the economic stimulus plan.

Lindsey H.

Ann Neurol. 2009 Feb;65(2):A9-A11. doi: 10.1002/ana.21683. No abstract available.

PMID:
19260032
11.

Comparative effectiveness casts first shadows across US industry.

Waltz E.

Nat Biotechnol. 2009 Mar;27(3):211-2. doi: 10.1038/nbt0309-211. No abstract available.

PMID:
19270651
12.

Economic over-stimulation?

Johnston SC, Hauser SL.

Ann Neurol. 2009 Apr;65(4):A7-8. doi: 10.1002/ana.21735. No abstract available.

PMID:
19399856
13.

A Call for Value in Cancer Research.

Gross CP, Emanuel EJ.

JAMA Oncol. 2016 Jan;2(1):11-2. doi: 10.1001/jamaoncol.2015.3706. No abstract available.

PMID:
26447464
14.

[Research, intellectual property and development. Its implications for Argentine science].

Gómez DE.

Medicina (B Aires). 2015;75(1):62-4. Spanish. No abstract available.

15.

Research funding. NIH in the post-doubling era: realities and strategies.

Zerhouni EA.

Science. 2006 Nov 17;314(5802):1088-90. No abstract available.

PMID:
17110557
16.

U.S. science and austerity. Darwinism vs. social engineering at NIH.

Kaiser J.

Science. 2011 Nov 11;334(6057):753-4. doi: 10.1126/science.334.6057.753. No abstract available.

PMID:
22076357
17.

A plan for sustainable funding for US biomedical research.

Hensley P, LaMattina JL.

Nat Rev Drug Discov. 2015 Feb;14(2):147. doi: 10.1038/nrd4454-c1. No abstract available.

PMID:
25633798
18.

Biomedical research in the USA: at the dawn of a golden age?

[No authors listed]

Lancet. 2016 Jan 2;387(10013):1. doi: 10.1016/S0140-6736(15)01348-3. No abstract available.

PMID:
26766330
19.

Federal funding for endoscopic research in the United States: 2003-2008.

Othman MO, Wallace MB.

Am J Gastroenterol. 2011 Feb;106(2):178-82. doi: 10.1038/ajg.2010.302.

PMID:
21301446
20.

A perspective on the support of scientific research.

Somberg JC.

Am J Ther. 2013 May-Jun;20(3):231. doi: 10.1097/MJT.0b013e3182974f89. No abstract available.

PMID:
23656965

Supplemental Content

Support Center